**Reduction in Staffing and Resources:** Since ICU Medical acquired Smiths, there has been a noticeable reduction in staffing and resources. This has significantly impacted our productivity and morale.
- **Closure of Labs:** Over the past year, several labs have been closed with no real focus plan or understanding across multiple sites, further hindering our ability to perform and innovate in the USA.
- **Lack of New Information:** Product Development Meetings often share information already available through company updates, with very little new or actionable information. There is no clear roadmap or plan for the future.
- **Disconnected Leadership:** There is a strong feeling of disconnection from the main company. ICU Medical seems to lack a unified voice and clear measures from leadership. This disconnection has led to uncertainty about the future and a lack of direction.
- **Negative Outlook for the Future:** Many on-site employees feel that the future of our site is bleak. There is a pervasive belief that operations might end by 2025, which is discouraging, especially for young individuals looking for career growth and stability.
